UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000020703
Receipt number R000023883
Scientific Title Research on Evaluating Stress Accumulation in an Isolation Environment that Simulate a Long Duration Space Mission
Date of disclosure of the study information 2016/01/22
Last modified on 2021/06/24 16:35:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Research on Evaluating Stress Accumulation in an Isolation Environment
that Simulate a Long Duration Space Mission

Acronym

Research on Evaluating Stress Accumulation in an Isolation Environment
that Simulate a Long Duration Space Mission

Scientific Title

Research on Evaluating Stress Accumulation in an Isolation Environment
that Simulate a Long Duration Space Mission

Scientific Title:Acronym

Research on Evaluating Stress Accumulation in an Isolation Environment
that Simulate a Long Duration Space Mission

Region

Japan


Condition

Condition

Healthy adult male only, or healthy adult male and female

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To narrow down stress markers that reflect a level of the stress objectively when placing a workload on participants in an isolated environment

Basic objectives2

Others

Basic objectives -Others

To narrow down stress markers that reflect a level of the stress objectively when placing a workload on participants in an isolated environment

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Narrowing down stress markers that reflect a level of the stress objectively

Key secondary outcomes

Changes in stress marker candidate levels when placing a workload on participants in an isolated environment


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

1)Prohibition on leaving the Isolation Chamber for 14 days, 2)Following the designated plan (to sleep/wake up at designated time, to perform tasks according to schedule), 3)Personal space available only in each sleeping compartment and bathroom/restroom, 4)No information and communication equipment, no internet usage, no game machines, no smoking, 5)Restriction on meals (only preserved foods simulating space foods being provided, and no caffeinated drinks or alcohol beverages allowed), 6)Restriction on hygiene (allowing for only short-time showers), 7)Restriction on exercise (First 8 subjects-muscle training permitted, second 8 subjects-exercise prohibited, third 8 subjects-50% VO2max bike exercise conducted for 15 min every day with other exercise prohibited)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

55 years-old >=

Gender

Male and Female

Key inclusion criteria

1. adult male only, or adult male and female
2. would like to participate closed chamber study as a subject.
3. agree with informed consent

Key exclusion criteria

1. have presence of chronic illness or medication
2. smoker
3. alcoholic, drug abuse
4. claustrophobia
5. food allergy
6. in the caused ill feelings by blood collection.
7. serious medical history (cerebrovascular disease, heart disease)
8. positive for tuberculosis test
9. are prohibited to participate in trail by safety manager

Target sample size

56


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Satoshi Furukawa, M.D., Ph.D.

Organization

Japan Aerospace Exploration Agency

Division name

Human Spaceflight Technology Directorate

Zip code


Address

2-1-1, Sengen, Tsukuba, Ibaraki, 305-8505, Japan

TEL

+81-50-3362-7648

Email

furukawa.satoshi@jaxa.jp


Public contact

Name of contact person

1st name
Middle name
Last name Natsuhiko Inoue, Ph.D.

Organization

Japan Aerospace Exploration Agency

Division name

Human Spaceflight Technology Directorate

Zip code


Address

2-1-1, Sengen, Tsukuba, Ibaraki, 305-8505, Japan

TEL

+81-50-3362-3528

Homepage URL


Email

inoue.natsuhiko@jaxa.jp


Sponsor or person

Institute

Japan Aerospace Exploration Agency

Institute

Department

Personal name



Funding Source

Organization

Japan Aerospace Exploration Agency

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

University of Tsukuba, University of Tokyo, National Defense Medical College, Shiseido, Yakult, Cellspect, KAKENHI'Living In Space'

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

筑波宇宙センター(茨城県)


Other administrative information

Date of disclosure of the study information

2016 Year 01 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

Submitted for publication

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 01 Month 15 Day

Date of IRB

2016 Year 01 Month 19 Day

Anticipated trial start date

2016 Year 01 Month 15 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Observe using video camera


Management information

Registered date

2016 Year 01 Month 22 Day

Last modified on

2021 Year 06 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023883


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name